Peter Sullivan is a Health Care Policy Reporter at Axios. He covers a range of topics within health care, including consumer health, pharmaceuticals, and public policy, often intertwining themes of wellness and politics. Peter's work has been featured in numerous outlets, including The Hill, WRBL News 3, and FOX 5 San Diego.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Peter Sullivan's coverage primarily focuses on national US government announcements, legal policy regulation, and healthcare-related themes. His articles often cover legislative actions related to healthcare policies, making him likely interested in pitches that provide insights into the impact of new legislation or regulatory changes on the healthcare industry.
Given his focus on government announcements and health policy, Peter may be receptive to expert commentary from individuals with direct experience in navigating legislative processes or implementing healthcare policies. Additionally, he might be interested in analysis from experts who can contextualize how specific regulations or bills could affect different stakeholders within the healthcare sector.
Since Peter's geographic focus is national (United States), relevant sources should have expertise in US healthcare legislation and a deep understanding of its potential implications at both federal and state levels.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The medical report didn't put to rest questions about bruising on Trump's hands, swollen ankles and his alertness.
Democratic states are pushing back on the Trump administration's rules for new Medicaid work requirements, warning that a chaotic rollout in the coming months could lead to even more people losing their coverage.
Why it matters: GOP lawmakers contend Medicare and Medicaid are rife with theft, but the new effort risks crossing the line into benefit cuts that could prompt political backlash in an election year.
Democrats argue Trump hasn't delivered meaningful results the way they did in 2022 through the Inflation Reduction Act.
A Senate plan to limit insulin costs in private insurance markets is getting new life after a key committee gave it bipartisan backing.
The first of what could be a slew of Trump health confirmation hearings will begin in July.
Customers could be on the hook for thousands of more dollars in costs, worsening the health affordability crisis.
By: Peter Sullivan
Why it matters: It would mark the second straight year of double-digit premium increases in the individual market.
That doesn't mean controversies around vaccines and public health are over.
The latest Senate debate over a Trump health appointment kicks off Wednesday with a less polarizing nominee than some of the president's previous picks — but that doesn't mean controversies around vaccines and public health are over.
